{
  "page": 7,
  "value": [
    {
      "path": "_news/2020-03-27-who-officials-enroll-first-patients-from-norway-and-spain-in-historic-coronavirus-drug-trial.md",
      "title": "WHO officials enroll first patients from Norway and Spain in 'historic' coronavirus drug trial",
      "excerpt": "World Health Organization officials are holding a press conference Friday to update the public on the coronavirus outbreak.",
      "heat": 113,
      "tags": [
        "Spain",
        "ES"
      ],
      "type": "article",
      "webUrl": "https://www.cnbc.com/2020/03/27/who-officials-enroll-first-patients-from-norway-and-spain-in-historic-coronavirus-drug-trial.html",
      "ampWebUrl": "https://www.cnbc.com/amp/2020/03/27/who-officials-enroll-first-patients-from-norway-and-spain-in-historic-coronavirus-drug-trial.html",
      "cdnAmpWebUrl": "https://www-cnbc-com.cdn.ampproject.org/c/s/www.cnbc.com/amp/2020/03/27/who-officials-enroll-first-patients-from-norway-and-spain-in-historic-coronavirus-drug-trial.html",
      "publishedDateTime": "2020-03-27T09:44:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CNBC",
        "domain": "cnbc.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cnbc.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://image.cnbcfm.com/api/v1/image/106454187-1584724017641gettyimages-1204797411.jpeg?v=1584724086",
          "width": 4000,
          "height": 2667,
          "title": "WHO officials enroll first patients from Norway and Spain in 'historic' coronavirus drug trial",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus",
        "Coronavirus in Europe"
      ]
    },
    {
      "path": "_news/2020-03-27-blood-from-people-who-recover-from-coronavirus-could-provide-a-treatment.md",
      "title": "Blood from people who recover from coronavirus could provide a treatment",
      "excerpt": "People who recover from the coronavirus could play an essential role in fighting the disease -- by donating plasma that could help others fight off infection.",
      "heat": 119,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.washingtonpost.com/health/2020/03/27/coronavirus-serum-plasma-treatment/",
      "ampWebUrl": "https://www.washingtonpost.com/health/2020/03/27/coronavirus-serum-plasma-treatment/?outputType=amp",
      "cdnAmpWebUrl": "https://www-washingtonpost-com.cdn.ampproject.org/c/s/www.washingtonpost.com/health/2020/03/27/coronavirus-serum-plasma-treatment/?outputType=amp",
      "publishedDateTime": "2020-03-27T08:48:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Washington Post",
        "domain": "washingtonpost.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/washingtonpost.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.washingtonpost.com/resizer/4ny46TGs-2rr-kclJi5lHEDBpZw=/1440x0/smart/arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/OFGO6LDOCII6VIKWABELMLG3KE.jpg",
          "width": 1440,
          "height": 1440,
          "title": "Blood from people who recover from coronavirus could provide a treatment",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-27-fact-check-drugmaker-gilead-sciences-claimed-rights-to-a-possible-covid-19-treatment.md",
      "title": "Fact check: Drugmaker Gilead Sciences claimed rights to a possible COVID-19 treatment",
      "excerpt": "Gilead Sciences received special FDA protection for the antiviral drug remdesivir. Facing criticism, it withdrew its request for \"orphan status.\"",
      "heat": 113,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.usatoday.com/story/news/factcheck/2020/03/27/fact-check-coronavirus-gilead-sciences-received-withdrew-fda-orphan-status-remdesivir/2922115001/",
      "ampWebUrl": "https://amp.usatoday.com/amp/2922115001",
      "cdnAmpWebUrl": "https://amp-usatoday-com.cdn.ampproject.org/c/s/amp.usatoday.com/amp/2922115001",
      "publishedDateTime": "2020-03-27T08:38:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "USA Today",
        "domain": "usatoday.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/usatoday.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.gannett-cdn.com/presto/2020/03/27/USAT/33caaba9-298d-4454-856d-f87f0c6c2a36-AFP_AFP_1Q78FJ.JPG?auto=webp&crop=5313,2989,x0,y353&format=pjpg&width=1200",
          "width": 1200,
          "height": 675,
          "title": "Fact check: Drugmaker Gilead Sciences claimed rights to a possible COVID-19 treatment",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-27-swiss-pharma-giant-says-its-too-soon-to-know-whether-malaria-drug-could-be-coronavirus-treatment.md",
      "title": "Swiss pharma giant says it's 'too soon' to know whether malaria drug could be coronavirus treatment",
      "excerpt": "The CEO of Novartis said it is \"too soon\" to know whether two anti-malaria drugs could be the definitive treatment for the coronavirus.",
      "heat": 106,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.cnbc.com/2020/03/27/coronavirus-vaccine-novartis-ceo-says-its-too-soon-to-know-whether-malaria-drugs-can-work.html",
      "ampWebUrl": "https://www.cnbc.com/amp/2020/03/27/coronavirus-vaccine-novartis-ceo-says-its-too-soon-to-know-whether-malaria-drugs-can-work.html",
      "cdnAmpWebUrl": "https://www-cnbc-com.cdn.ampproject.org/c/s/www.cnbc.com/amp/2020/03/27/coronavirus-vaccine-novartis-ceo-says-its-too-soon-to-know-whether-malaria-drugs-can-work.html",
      "publishedDateTime": "2020-03-27T08:18:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CNBC",
        "domain": "cnbc.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cnbc.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://image.cnbcfm.com/api/v1/image/105932498-1558717769811gettyimages-1088275184.jpeg?v=1584735079",
          "width": 4697,
          "height": 3131,
          "title": "Swiss pharma giant says it's 'too soon' to know whether malaria drug could be coronavirus treatment",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-27-people-in-addiction-treatment-are-losing-crucial-support-during-coronavirus-pandemic.md",
      "title": "People in addiction treatment are losing crucial support during coronavirus pandemic",
      "excerpt": "It’s why, until recently, he was showing up three days a week in suburban Maryland, leading group support sessions before heading to his midnight shift as a project manager for Metro. “Isolation is a luxury that you have to learn to grow into,",
      "heat": null,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.washingtonpost.com/health/people-in-addiction-treatment-are-losing-crucial-support-during-coronavirus-pandemic/2020/03/26/5698eae0-6ac6-11ea-abef-020f086a3fab_story.html",
      "ampWebUrl": "https://www.washingtonpost.com/health/people-in-addiction-treatment-are-losing-crucial-support-during-coronavirus-pandemic/2020/03/26/5698eae0-6ac6-11ea-abef-020f086a3fab_story.html?outputType=amp",
      "cdnAmpWebUrl": "https://www-washingtonpost-com.cdn.ampproject.org/c/s/www.washingtonpost.com/health/people-in-addiction-treatment-are-losing-crucial-support-during-coronavirus-pandemic/2020/03/26/5698eae0-6ac6-11ea-abef-020f086a3fab_story.html?outputType=amp",
      "publishedDateTime": "2020-03-27T05:28:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Washington Post",
        "domain": "washingtonpost.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/washingtonpost.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.washingtonpost.com/resizer/TzNGkOr_E4NtY6vYc3QgOX5RqzE=/1440x0/smart/arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/UV53VVTO4MI6VIKWABELMLG3KE.jpg",
          "width": 1440,
          "height": 960,
          "title": "People in addiction treatment are losing crucial support during coronavirus pandemic",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-27-teens-are-discovering-a-cure-for-coronavirus-anxiety-walks-no-phones-allowed.md",
      "title": "Teens are discovering a cure for coronavirus anxiety: Walks. No phones allowed.",
      "excerpt": "For a half-hour or so, she walks. She chooses random directions at the four-way intersections that dot her neighborhood. She stops to feel the spring sunlight on her skin. She leans in, close, to look at dandelions.",
      "heat": 101,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.washingtonpost.com/local/education/teens-are-discovering-a-cure-for-coronavirus-anxiety-walks-no-phones-allowed/2020/03/26/ca2e36ba-6c40-11ea-aa80-c2470c6b2034_story.html",
      "ampWebUrl": "https://www.washingtonpost.com/local/education/teens-are-discovering-a-cure-for-coronavirus-anxiety-walks-no-phones-allowed/2020/03/26/ca2e36ba-6c40-11ea-aa80-c2470c6b2034_story.html?outputType=amp",
      "cdnAmpWebUrl": "https://www-washingtonpost-com.cdn.ampproject.org/c/s/www.washingtonpost.com/local/education/teens-are-discovering-a-cure-for-coronavirus-anxiety-walks-no-phones-allowed/2020/03/26/ca2e36ba-6c40-11ea-aa80-c2470c6b2034_story.html?outputType=amp",
      "publishedDateTime": "2020-03-27T04:16:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Washington Post",
        "domain": "washingtonpost.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/washingtonpost.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.washingtonpost.com/resizer/h6ZYna48ZWxXELpXyeLppAogOCo=/1440x0/smart/arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/HXYU7BTO4EI6VIKWABELMLG3KE.jpg",
          "width": 1440,
          "height": 1920,
          "title": "Teens are discovering a cure for coronavirus anxiety: Walks. No phones allowed.",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-27-experimental-coronavirus-treatments-surprising-orphan-designation.md",
      "title": "Experimental coronavirus treatment's surprising \"orphan\" designation",
      "excerpt": "Background: Pharmaceutical company Gilead Sciences is running clinical trials to test whether one of its drugs, called remdesivir, is an effective treatment against the novel coronavirus. On Monday, the FDA granted remdesivir status as an \"orphan\" drug. Orphan status is reserved for drugs that treat rare diseases. It gives their developers ...",
      "heat": 100,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.axios.com/remdesivir-orphan-designation-coronavirus-f5aaedcf-f2b8-4874-89ab-433e2561b60e.html",
      "ampWebUrl": "https://www.axios.com/remdesivir-orphan-designation-coronavirus-f5aaedcf-f2b8-4874-89ab-433e2561b60e.html",
      "cdnAmpWebUrl": "https://www-axios-com.cdn.ampproject.org/c/s/www.axios.com/remdesivir-orphan-designation-coronavirus-f5aaedcf-f2b8-4874-89ab-433e2561b60e.html",
      "publishedDateTime": "2020-03-27T03:49:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Axios",
        "domain": "axios.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://images.axios.com/z8KiAp7mXrvHDYeEm2C6yCJ7XCM=/2020/03/27/1585305124428.jpg",
          "width": 4823,
          "height": 3295,
          "title": "Experimental coronavirus treatment's surprising \"orphan\" designation",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-27-coronavirus-treatment-israel-to-use-unapproved-drug-to-treat-covid-19.md",
      "title": "Coronavirus Treatment: Israel To Use Unapproved Drug To Treat COVID-19",
      "excerpt": "The unapproved drug is a mix of lopinavir and ritonavir and is manufactured by American biopharmaceutical firm AbbVie.",
      "heat": 105,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.ibtimes.com/coronavirus-treatment-israel-use-unapproved-drug-treat-covid-19-2947804",
      "ampWebUrl": "https://www.ibtimes.com/coronavirus-treatment-israel-use-unapproved-drug-treat-covid-19-2947804?amp=1",
      "cdnAmpWebUrl": "https://www-ibtimes-com.cdn.ampproject.org/c/s/www.ibtimes.com/coronavirus-treatment-israel-use-unapproved-drug-treat-covid-19-2947804?amp=1",
      "publishedDateTime": "2020-03-26T23:07:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "International Business Times",
        "domain": "ibtimes.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s1.ibtimes.com/sites/www.ibtimes.com/files/styles/full/public/2020/03/19/a-fransiscan-friar-stops-in-front-of-closed.jpg",
          "width": 1024,
          "height": 682,
          "title": "Coronavirus Treatment: Israel To Use Unapproved Drug To Treat COVID-19",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-27-coronavirus-treatment-hiv-drug-used-to-cure-covid-19-positive-british-national-in-india.md",
      "title": "Coronavirus Treatment: HIV Drug Used To Cure COVID-19 Positive British National In India",
      "excerpt": "As the world battles the coronavirus pandemic, doctors throughout the world have been experimenting with several drugs to treat coronavirus patients. Doctors in Kerala, India have begun using anti-HIV medicines on COVID-19 patients.",
      "heat": 106,
      "tags": [
        "India",
        "IN"
      ],
      "type": "article",
      "webUrl": "https://www.ibtimes.com/coronavirus-treatment-hiv-drug-used-cure-covid-19-positive-british-national-india-2947136",
      "ampWebUrl": "https://www.ibtimes.com/coronavirus-treatment-hiv-drug-used-cure-covid-19-positive-british-national-india-2947136?amp=1",
      "cdnAmpWebUrl": "https://www-ibtimes-com.cdn.ampproject.org/c/s/www.ibtimes.com/coronavirus-treatment-hiv-drug-used-cure-covid-19-positive-british-national-india-2947136?amp=1",
      "publishedDateTime": "2020-03-26T20:13:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "International Business Times",
        "domain": "ibtimes.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s1.ibtimes.com/sites/www.ibtimes.com/files/styles/full/public/2017/02/02/researchers-receive-25-million-funding-test-combined-hiv-drugs-patients.png",
          "width": 600,
          "height": 544,
          "title": "Coronavirus Treatment: HIV Drug Used To Cure COVID-19 Positive British National In India",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus",
        "Coronavirus in Asia"
      ]
    },
    {
      "path": "_news/2020-03-27-coronavirus-the-latest-in-drug-treatment-and-vaccine-development.md",
      "title": "Coronavirus: The latest in drug treatment and vaccine development",
      "excerpt": "This undated transmission electron microscope image shows the novel coronavirus, the virus that causes COVID ... Here are the latest developments in the research. March 26: University of Manitoba researchers begin recruiting participants for a series of trials to test whether the malaria drug hydroxychloroquine can reduce the symptoms and ...",
      "heat": 105,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.cbc.ca/news/health/coronavirus-treatment-and-vaccine-development-1.5511346",
      "ampWebUrl": "https://www.cbc.ca/amp/1.5511346",
      "cdnAmpWebUrl": "https://www-cbc-ca.cdn.ampproject.org/c/s/www.cbc.ca/amp/1.5511346",
      "publishedDateTime": "2020-03-26T18:07:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CBC.ca",
        "domain": "www.cbc.ca",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://i.cbc.ca/1.5509820.1585164070!/fileImage/httpImage/image.JPG_gen/derivatives/16x9_620/health-coronavirus-usa.JPG",
          "width": 620,
          "height": 349,
          "title": "Coronavirus: The latest in drug treatment and vaccine development",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-26-coronavirus-vaccines-the-drugs-in-development-to-treat-covid-19.md",
      "title": "Coronavirus vaccines: The drugs in development to treat COVID-19",
      "excerpt": "Researchers are racing to develop new treatments and therapies to tackle the coronavirus pandemic. Here's what you need to know about them.",
      "heat": 120,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.cnet.com/how-to/coronavirus-vaccines-the-drugs-in-development-to-treat-covid-19/",
      "ampWebUrl": "https://www.cnet.com/google-amp/news/coronavirus-vaccines-the-drugs-in-development-to-treat-covid-19/",
      "cdnAmpWebUrl": "https://www-cnet-com.cdn.ampproject.org/c/s/www.cnet.com/google-amp/news/coronavirus-vaccines-the-drugs-in-development-to-treat-covid-19/",
      "publishedDateTime": "2020-03-26T16:31:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "CNET",
        "domain": "cnet.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/cnet.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://cnet4.cbsistatic.com/img/bFGoWxsdS_r19mxEEKF4_d6wQig=/0x0:1225x1089/756x567/2020/03/14/8b6352f3-8a43-4b7c-86de-5a105ff52d29/gettyimages-144560269.jpg",
          "width": 756,
          "height": 567,
          "title": "Coronavirus vaccines: The drugs in development to treat COVID-19",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-26-coronavirus-a-new-type-of-vaccine-using-rna-could-help-defeat-covid-19.md",
      "title": "Coronavirus: a new type of vaccine using RNA could help defeat COVID-19",
      "excerpt": "SARS-CoV-2, like other coronaviruses, is named for the crown-like spikes on its surface ... An mRNA vaccine for COVID-19 to undergo trial Using this strategy, biotechnology firm Moderna Inc. announced on Feb. 24 that it had rapidly developed an experimental COVID-19 mRNA vaccine called mRNA-1273, ready for clinical trials in humans.",
      "heat": 100,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.rawstory.com/2020/03/coronavirus-a-new-type-of-vaccine-using-rna-could-help-defeat-covid-19/",
      "ampWebUrl": "https://www.rawstory.com/2020/03/coronavirus-a-new-type-of-vaccine-using-rna-could-help-defeat-covid-19/amp/",
      "cdnAmpWebUrl": "https://www-rawstory-com.cdn.ampproject.org/c/s/www.rawstory.com/2020/03/coronavirus-a-new-type-of-vaccine-using-rna-could-help-defeat-covid-19/amp/",
      "publishedDateTime": "2020-03-26T13:14:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "The Raw Story",
        "domain": "rawstory.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.rawstory.com/wp-content/uploads/2020/03/This-scanning-electron-microscope-image-shows-SARS-CoV-2-round-blue-objects-emerging-from-the-surface-of-cells-cultured-in-the-lab.-NIAID-RML.jpeg",
          "width": 640,
          "height": 314,
          "title": "Coronavirus: a new type of vaccine using RNA could help defeat COVID-19",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-26-republican-billionaires-group-pushes-unproven-covid-19-treatment-trump-promoted.md",
      "title": "Republican Billionaire’s Group Pushes Unproven COVID-19 Treatment Trump Promoted",
      "excerpt": "A conservative business group founded by a prolific Republican political donor is pressuring the White House to greenlight an unproven COVID-19 treatment, saying in an online petition that the country has plants in the U.S. ready to produce a drug but can’t because of “red tape, regulation, and a dysfunctional healthcare supply chain.”",
      "heat": null,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.propublica.org/article/republican-billionaire-group-pushes-unproven-covid-19-treatment-trump-promoted",
      "ampWebUrl": null,
      "cdnAmpWebUrl": null,
      "publishedDateTime": "2020-03-26T10:35:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "ProPublica",
        "domain": "propublica.org",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://assets.propublica.org/images/articles/20200326-covid-treatment-billionaire-1200x630.jpg",
          "width": 1200,
          "height": 630,
          "title": "Republican Billionaire’s Group Pushes Unproven COVID-19 Treatment Trump Promoted",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-26-sanofi-regeneron-begin-testing-arthritis-drug-as-coronavirus-treatment.md",
      "title": "Sanofi, Regeneron begin testing arthritis drug as coronavirus treatment",
      "excerpt": "Sanofi SA and partner Regeneron Pharmaceuticals Inc have started a clinical trial of their rheumatoid arthritis drug Kevzara as a treatment for the coronavirus, the companies said on Monday. Enrolments for the mid-to-late stage trial will begin immediately,",
      "heat": 135,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.reuters.com/article/us-health-coronavirus-regeneron-pharms-s-idUSKBN2131TP",
      "ampWebUrl": "https://mobile.reuters.com/article/amp/idUSKBN2131TP",
      "cdnAmpWebUrl": "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSKBN2131TP",
      "publishedDateTime": "2020-03-26T07:37:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s4.reutersmedia.net/resources/r/?m=02&d=20200316&t=2&i=1503946701&w=&fh=545px&fw=&ll=&pl=&sq=&r=LYNXMPEG2F17R",
          "width": 862,
          "height": 545,
          "title": "Sanofi, Regeneron begin testing arthritis drug as coronavirus treatment",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-26-blood-plasma-treatment-for-coronavirus-set-to-get-its-first-trial-run-in-new-york.md",
      "title": "Blood Plasma Treatment For Coronavirus Set to Get Its First Trial Run in New York",
      "excerpt": "The New York Blood Center (NYBC) is the first blood-gathering organization in the U.S. to collect plasma from COVID-19 patients to use as a possible treatment for the disease. Before antibiotics rendered the practice moot, it was common to treat infectious bacterial diseases by infusing the blood of recovered patients into those struggling with ...",
      "heat": 105,
      "tags": [
        "US-NY"
      ],
      "type": "article",
      "webUrl": "https://time.com/5809955/blood-plasma-coronavirus/",
      "ampWebUrl": "https://time.com/5809955/blood-plasma-coronavirus/?amp=true",
      "cdnAmpWebUrl": "https://time-com.cdn.ampproject.org/c/s/time.com/5809955/blood-plasma-coronavirus/?amp=true",
      "publishedDateTime": "2020-03-26T04:42:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Time",
        "domain": "time.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/time.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": null,
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Coronavirus in US",
        "Coronavirus",
        "Treatment"
      ]
    },
    {
      "path": "_news/2020-03-26-better-coronavirus-stock-gilead-sciences-vs-moderna.md",
      "title": "Better Coronavirus Stock: Gilead Sciences vs. Moderna",
      "excerpt": "Follow @keithspeights Quite a few drugmakers are racing to develop antiviral therapies to combat novel coronavirus disease COVID-19 and vaccines to immunize against infection from the virus. Two of the clear leaders on both of these fronts are Gilead Sciences (NASDAQ:GILD) and Moderna (NASDAQ:MRNA). Both stocks have performed relatively well ...",
      "heat": 130,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.fool.com/investing/2020/03/26/better-coronavirus-stock-gilead-sciences-vs-modern.aspx",
      "ampWebUrl": "https://www.fool.com/amp/investing/2020/03/26/better-coronavirus-stock-gilead-sciences-vs-modern.aspx",
      "cdnAmpWebUrl": "https://www-fool-com.cdn.ampproject.org/c/s/www.fool.com/amp/investing/2020/03/26/better-coronavirus-stock-gilead-sciences-vs-modern.aspx",
      "publishedDateTime": "2020-03-26T04:20:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "The Motley Fool",
        "domain": "fool.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/fool.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F565062%2Fcovid-19-coronavirus-wood-blocks.jpg&w=1200&op=resize",
          "width": 1200,
          "height": 675,
          "title": "Better Coronavirus Stock: Gilead Sciences vs. Moderna",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus",
        "Stock Impact"
      ]
    },
    {
      "path": "_news/2020-03-26-small-time-actor-peddled-fake-coronavirus-cure-to-millions-online-feds-charge-in-first-covid-19-prosecution.md",
      "title": "Small-time actor peddled fake coronavirus cure to millions online, feds charge in first covid-19 prosecution",
      "excerpt": "The Justice Department brought its first coronavirus-related criminal fraud case in the nation on Wednesday night, accusing a small-time actor in Southern California of peddling a fake cure to millions of his and trying to woo investors with promises of millions of dollars in returns.",
      "heat": 121,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.washingtonpost.com/nation/2020/03/26/fake-coronavirus-cure-fraud/",
      "ampWebUrl": "https://www.washingtonpost.com/nation/2020/03/26/fake-coronavirus-cure-fraud/?outputType=amp",
      "cdnAmpWebUrl": "https://www-washingtonpost-com.cdn.ampproject.org/c/s/www.washingtonpost.com/nation/2020/03/26/fake-coronavirus-cure-fraud/?outputType=amp",
      "publishedDateTime": "2020-03-26T03:39:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Washington Post",
        "domain": "washingtonpost.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/washingtonpost.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.washingtonpost.com/resizer/wOX_a0TGMAsDnz_xI6zv5gGbukA=/1440x0/smart/arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/4JMVWUIU4ZFCBJDHPSB75C7QZU.png",
          "width": 1440,
          "height": 788,
          "title": "Small-time actor peddled fake coronavirus cure to millions online, feds charge in first covid-19 prosecution",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Coronavirus",
        "Treatment"
      ]
    },
    {
      "path": "_news/2020-03-26-gilead-asks-fda-to-revoke-orphan-drug-status-for-potential-coronavirus-drug.md",
      "title": "Gilead asks FDA to revoke orphan drug status for potential coronavirus drug",
      "excerpt": "Gilead Sciences Inc said on Wednesday it had requested the U.S. Food and Drug administration to rescind the “orphan drug” status for its experimental drug, remdesivir, seen as one of the more promising potential treatments for the coronavirus.",
      "heat": 133,
      "tags": null,
      "type": "article",
      "webUrl": "https://in.reuters.com/article/health-coronavirus-gilead-sciences-idINL4N2BI4NV",
      "ampWebUrl": "https://in.mobile.reuters.com/article/amp/idINL4N2BI4NV",
      "cdnAmpWebUrl": "https://in-mobile-reuters-com.cdn.ampproject.org/c/s/in.mobile.reuters.com/article/amp/idINL4N2BI4NV",
      "publishedDateTime": "2020-03-26T00:52:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Reuters",
        "domain": "reuters.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s4.reutersmedia.net/resources_v3/images/rcom-default.png",
          "width": 1200,
          "height": 630,
          "title": "Gilead asks FDA to revoke orphan drug status for potential coronavirus drug",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-26-connecticut-company-biosig-acquires-rights-to-potential-coronavirus-cure-report.md",
      "title": "Connecticut company BioSig acquires rights to potential coronavirus cure: report",
      "excerpt": "A Connecticut maker of computers used by heart surgeons says one of its subsidiaries has acquired the rights to an antiviral product that is said to have potential as a coronavirus treatment. BioSig Technologies of Westport said in a statement that its NeuroClear Technoligies unit has acquired the rights to Vicromax,",
      "heat": 110,
      "tags": [
        "US-CT"
      ],
      "type": "article",
      "webUrl": "https://www.foxnews.com/us/connecticut-company-biosig-acquires-rights-to-potential-coronavirus-cure-report",
      "ampWebUrl": "https://www.foxnews.com/us/connecticut-company-biosig-acquires-rights-to-potential-coronavirus-cure-report.amp",
      "cdnAmpWebUrl": "https://www-foxnews-com.cdn.ampproject.org/c/s/www.foxnews.com/us/connecticut-company-biosig-acquires-rights-to-potential-coronavirus-cure-report.amp",
      "publishedDateTime": "2020-03-25T22:05:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Fox News",
        "domain": "foxnews.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/foxnews.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://cf-images.us-east-1.prod.boltdns.net/v1/static/694940094001/096e396e-0212-401d-899d-3e1eb30d3d3c/33b33136-d6d9-4225-a51b-8d710304f74f/1280x720/match/image.jpg",
          "width": 1280,
          "height": 720,
          "title": "Connecticut company BioSig acquires rights to potential coronavirus cure: report",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Coronavirus in US",
        "Coronavirus",
        "Treatment"
      ]
    },
    {
      "path": "_news/2020-03-26-coronavirus-treatment-china-touts-bear-bile-as-covid-19-cure.md",
      "title": "Coronavirus Treatment: China Touts Bear Bile As COVID-19 Cure",
      "excerpt": "The Europeans recently announced a successful operation to remove fake COVID-19 medicines from markets worldwide Traditional Chinese medicine believes bear bile can cure COVID-19 The internet is flooded with fake products and fake cures for COVID-19.",
      "heat": 105,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.ibtimes.com/coronavirus-treatment-china-touts-bear-bile-covid-19-cure-2946942",
      "ampWebUrl": "https://www.ibtimes.com/coronavirus-treatment-china-touts-bear-bile-covid-19-cure-2946942?amp=1",
      "cdnAmpWebUrl": "https://www-ibtimes-com.cdn.ampproject.org/c/s/www.ibtimes.com/coronavirus-treatment-china-touts-bear-bile-covid-19-cure-2946942?amp=1",
      "publishedDateTime": "2020-03-25T21:51:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "International Business Times",
        "domain": "ibtimes.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s1.ibtimes.com/sites/www.ibtimes.com/files/styles/full/public/2017/11/28/himalayan-brown-bear.jpg",
          "width": 1200,
          "height": 828,
          "title": "Coronavirus Treatment: China Touts Bear Bile As COVID-19 Cure",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-26-gilead-asks-the-fda-to-rescind-orphan-drug-designation-for-remdesivir-as-a-treatment-for-covid-19.md",
      "title": "Gilead Asks the FDA to Rescind Orphan Drug Designation for Remdesivir as a Treatment for COVID-19",
      "excerpt": "Follow @BiologyFool Gilead Sciences (NASDAQ:GILD) has asked the Food and Drug Administration to rescind the orphan drug designation it was awarded for remdesivir as a treatment for COVID-19, the disease caused by the new coronavirus. On Monday, Gilead got some backlash on Twitter for announcing the orphan drug designation, because the ...",
      "heat": 107,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.fool.com/investing/2020/03/25/gilead-asks-the-fda-to-rescind-orphan-drug-designa.aspx",
      "ampWebUrl": "https://www.fool.com/amp/investing/2020/03/25/gilead-asks-the-fda-to-rescind-orphan-drug-designa.aspx",
      "cdnAmpWebUrl": "https://www-fool-com.cdn.ampproject.org/c/s/www.fool.com/amp/investing/2020/03/25/gilead-asks-the-fda-to-rescind-orphan-drug-designa.aspx",
      "publishedDateTime": "2020-03-25T19:10:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "The Motley Fool",
        "domain": "fool.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/fool.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F565264%2Fcoronavirus-patient-2.jpg&w=1200&op=resize",
          "width": 1200,
          "height": 798,
          "title": "Gilead Asks the FDA to Rescind Orphan Drug Designation for Remdesivir as a Treatment for COVID-19",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-26-dr-ben-carson-plasma-transfusion-coronavirus-treatment-being-tested-by-new-york-looks-promising.md",
      "title": "Dr. Ben Carson: Plasma transfusion coronavirus treatment being tested by New York looks 'promising'",
      "excerpt": "Housing and Urban Development Secretary Ben Carson told \"The Story\" Wednesday that there is promise in a new therapy to fight the coronavirus contagion.",
      "heat": 111,
      "tags": [
        "US-NY"
      ],
      "type": "article",
      "webUrl": "https://www.foxnews.com/media/dr-ben-carson-plasma-transfusion-coronavirus-treatment",
      "ampWebUrl": null,
      "cdnAmpWebUrl": null,
      "publishedDateTime": "2020-03-25T18:11:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Fox News",
        "domain": "foxnews.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/foxnews.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://a57.foxnews.com/cf-images.us-east-1.prod.boltdns.net/v1/static/694940094001/b170bb0a-63f6-4e33-9cdb-af59c7461952/8269961c-47aa-468f-a98c-85d5649ef266/1280x720/match/931/524/image.jpg?ve=1&tl=1",
          "width": 931,
          "height": 524,
          "title": "Dr. Ben Carson: Plasma transfusion coronavirus treatment being tested by New York looks 'promising'",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus",
        "Coronavirus in US"
      ]
    },
    {
      "path": "_news/2020-03-26-drug-companies-ramp-up-research-for-a-coronavirus-treatment-or-vaccine.md",
      "title": "Drug companies ramp up research for a coronavirus treatment or vaccine",
      "excerpt": "But some experimental treatments, while they still require more research, are showing promise ... patients suffering from the novel coronavirus, according to a senior Health and Human Services official and another source with direct knowledge. Why it matters: It doesn't hurt to have a potential treatment on hand, but we're still a very long ...",
      "heat": 105,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.axios.com/coronavirus-treatment-vaccine-research-pharma-drugs-55a28ea3-ee91-4f77-a093-44d450470b25.html",
      "ampWebUrl": "https://www.axios.com/coronavirus-treatment-vaccine-research-pharma-drugs-55a28ea3-ee91-4f77-a093-44d450470b25.html",
      "cdnAmpWebUrl": "https://www-axios-com.cdn.ampproject.org/c/s/www.axios.com/coronavirus-treatment-vaccine-research-pharma-drugs-55a28ea3-ee91-4f77-a093-44d450470b25.html",
      "publishedDateTime": "2020-03-25T17:00:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Axios",
        "domain": "axios.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://images.axios.com/gZVVSLyhFLOtk_BjqYIUE7MI_7I=/2020/03/24/1585087556381.jpg",
          "width": 5184,
          "height": 3456,
          "title": "Drug companies ramp up research for a coronavirus treatment or vaccine",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-25-india-bans-export-of-drug-touted-by-trump-as-potential-coronavirus-treatment.md",
      "title": "India bans export of drug touted by Trump as potential coronavirus treatment",
      "excerpt": "India has banned the export of a malaria drug touted by President Trump as a \"game changer\" in the fight against the coronavirus pandemic.",
      "heat": 107,
      "tags": [
        "India",
        "IN",
        "US"
      ],
      "type": "article",
      "webUrl": "https://thehill.com/policy/international/489559-india-bans-export-of-drug-touted-by-trump-as-potential-coronavirus",
      "ampWebUrl": "https://thehill.com/policy/international/489559-india-bans-export-of-drug-touted-by-trump-as-potential-coronavirus?amp",
      "cdnAmpWebUrl": "https://thehill-com.cdn.ampproject.org/c/s/thehill.com/policy/international/489559-india-bans-export-of-drug-touted-by-trump-as-potential-coronavirus?amp",
      "publishedDateTime": "2020-03-25T16:17:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "The Hill",
        "domain": "thehill.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://thehill.com/sites/default/files/hydroxychloroquine_032520getty.jpg",
          "width": 980,
          "height": 551,
          "title": "India bans export of drug touted by Trump as potential coronavirus treatment",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus",
        "Coronavirus in Asia",
        "Coronavirus in US"
      ]
    },
    {
      "path": "_news/2020-03-25-balancing-covid-19-with-a-destructive-cure.md",
      "title": "Balancing Covid-19 With a Destructive Cure",
      "excerpt": "As someone who is statistically at high risk for Covid-19, I am indescribably grateful to my fellow citizens for the heroic sacrifices they are making to keep me safe. But I don’t think trashing the economy is the long-term answer for anybody.",
      "heat": 105,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.wsj.com/articles/balancing-covid-19-with-a-destructive-cure-11585158209",
      "ampWebUrl": "https://www.wsj.com/amp/articles/balancing-covid-19-with-a-destructive-cure-11585158209",
      "cdnAmpWebUrl": "https://www-wsj-com.cdn.ampproject.org/c/s/www.wsj.com/amp/articles/balancing-covid-19-with-a-destructive-cure-11585158209",
      "publishedDateTime": "2020-03-25T15:43:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Wall Street Journal",
        "domain": "wsj.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/wsj.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://images.wsj.net/im-166916/social",
          "width": 1280,
          "height": 640,
          "title": "Balancing Covid-19 With a Destructive Cure",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-25-gilead-asks-the-fda-to-rescind-orphan-drug-designation-for-remdesivir-as-a-treatment-for-covid-19.md",
      "title": "Gilead Asks the FDA to Rescind Orphan Drug Designation for Remdesivir as a Treatment for COVID-19",
      "excerpt": "Gilead Sciences (NASDAQ: GILD) has asked the Food and Drug Administration to rescind the orphan drug designation it was awarded for remdesivir as a treatment for COVID-19, the disease caused by the new coronavirus.",
      "heat": 127,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.nasdaq.com/articles/gilead-asks-the-fda-to-rescind-orphan-drug-designation-for-remdesivir-as-a-treatment-for",
      "ampWebUrl": "https://www.nasdaq.com/articles/gilead-asks-the-fda-to-rescind-orphan-drug-designation-for-remdesivir-as-a-treatment-for?amp",
      "cdnAmpWebUrl": "https://www-nasdaq-com.cdn.ampproject.org/c/s/www.nasdaq.com/articles/gilead-asks-the-fda-to-rescind-orphan-drug-designation-for-remdesivir-as-a-treatment-for?amp",
      "publishedDateTime": "2020-03-25T15:36:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Nasdaq",
        "domain": "nasdaq.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?2015036400",
          "width": 1024,
          "height": 512,
          "title": "Gilead Asks the FDA to Rescind Orphan Drug Designation for Remdesivir as a Treatment for COVID-19",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-25-cardi-b-criticizes-government-over-coronavirus-response-calls-out-celebs-getting-special-treatment.md",
      "title": "Cardi B criticizes government over coronavirus response, calls out celebs getting special treatment",
      "excerpt": "Cardi B is sounding off on the developments surrounding the coronavirus, and issued a message for the government, as well as celebrities she believes are “causing confusion” for the general public by announcing that they’ve tested positive for the novel virus,",
      "heat": 106,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.foxnews.com/entertainment/cardi-b-slams-government-coronavirus-celebs-special-treatment",
      "ampWebUrl": "https://www.foxnews.com/entertainment/cardi-b-slams-government-coronavirus-celebs-special-treatment.amp",
      "cdnAmpWebUrl": "https://www-foxnews-com.cdn.ampproject.org/c/s/www.foxnews.com/entertainment/cardi-b-slams-government-coronavirus-celebs-special-treatment.amp",
      "publishedDateTime": "2020-03-25T14:42:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Fox News",
        "domain": "foxnews.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/foxnews.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2020/03/640/320/GettyImages-1027412730.jpg?ve=1&tl=1",
          "width": 640,
          "height": 320,
          "title": "Cardi B criticizes government over coronavirus response, calls out celebs getting special treatment",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-25-coronavirus-live-updates-debate-over-jobless-benefits-stalls-senate-vote-on-2-trillion-aid-package.md",
      "title": "Coronavirus Live Updates: Debate Over Jobless Benefits Stalls Senate Vote on $2 Trillion Aid Package",
      "excerpt": "Four Republican senators said the generous unemployment provisions in the bill could incentivize layoffs and discourage employees from seeking new jobs. Senate leaders still hoped to vote on the measure later Wednesday.",
      "heat": 100,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.nytimes.com/2020/03/25/world/coronavirus-news-live.html",
      "ampWebUrl": "https://www.nytimes.com/2020/03/25/world/coronavirus-news-live.amp.html",
      "cdnAmpWebUrl": "https://www-nytimes-com.cdn.ampproject.org/c/s/www.nytimes.com/2020/03/25/world/coronavirus-news-live.amp.html",
      "publishedDateTime": "2020-03-25T14:32:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "New York Times",
        "domain": "nytimes.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/nytimes.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://www.nytimes.com/newsgraphics/2020/03/04/corona-virus-social-images/assets/promo.jpg?u=1585174628581",
          "width": 1050,
          "height": 550,
          "title": "Coronavirus Live Updates: Debate Over Jobless Benefits Stalls Senate Vote on $2 Trillion Aid Package",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus",
        "Stock Impact"
      ]
    },
    {
      "path": "_news/2020-03-25-drugmaker-gilead-backpedals-on-specialty-status-for-covid-19-drug.md",
      "title": "Drugmaker Gilead backpedals on specialty status for COVID-19 drug",
      "excerpt": "WASHINGTON — Facing public criticism, the maker of a promising coronavirus drug said Wednesday it will waive a special regulatory designation that could have allowed it to block competition and boost profits for its treatment.",
      "heat": 115,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.marketwatch.com/story/drugmaker-gilead-backpedals-on-specialty-status-for-covid-19-drug-2020-03-25",
      "ampWebUrl": "https://www.marketwatch.com/amp/story/guid/EE5F43F8-6ED9-11EA-AAF7-27D4E02D4722",
      "cdnAmpWebUrl": "https://www-marketwatch-com.cdn.ampproject.org/c/s/www.marketwatch.com/amp/story/guid/EE5F43F8-6ED9-11EA-AAF7-27D4E02D4722",
      "publishedDateTime": "2020-03-25T13:51:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "MarketWatch",
        "domain": "marketwatch.com",
        "images": [
          {
            "url": "https://insideout.app/coronavirus/assets/images/organizations/marketwatch.com-50x50.jpg",
            "width": 50,
            "height": 50,
            "title": null,
            "attribution": null
          }
        ],
        "publishers": null,
        "authors": null
      },
      "images": [
        {
          "url": "https://s.marketwatch.com/public/resources/images/MW-HN288_gilead_ZH_20190714170014.jpg",
          "width": 890,
          "height": 501,
          "title": "Drugmaker Gilead backpedals on specialty status for COVID-19 drug",
          "attribution": null
        }
      ],
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    },
    {
      "path": "_news/2020-03-25-gilead-asks-fda-to-revoke-orphan-drug-status-for-potential-coronavirus-drug.md",
      "title": "Gilead asks FDA to revoke orphan drug status for potential coronavirus drug",
      "excerpt": "Gilead Sciences Inc said on Wednesday it had requested the U.S. Food and Drug Administration to rescind the \"orphan drug\" status for its experimental drug, remdesivir, seen as one of the more promising potential treatments for coronavirus,",
      "heat": null,
      "tags": null,
      "type": "article",
      "webUrl": "https://www.nasdaq.com/articles/gilead-asks-fda-to-revoke-orphan-drug-status-for-potential-coronavirus-drug-2020-03-25",
      "ampWebUrl": null,
      "cdnAmpWebUrl": null,
      "publishedDateTime": "2020-03-25T11:20:00-07:00",
      "updatedDateTime": null,
      "provider": {
        "name": "Nasdaq",
        "domain": "nasdaq.com",
        "images": null,
        "publishers": null,
        "authors": null
      },
      "images": null,
      "locale": "en-us",
      "categories": [
        "news"
      ],
      "topics": [
        "Treatment",
        "Coronavirus"
      ]
    }
  ],
  "nextPage": 8
}